Gastric Enteroendocrine Cells are specialized cells scattered throughout the lining of the stomach, primarily in the gastric glands. These cells serve as essential components of the gastrointestinal endocrine system, producing various hormones that play crucial roles in regulating digestive processes. Some of the key hormones released by gastric enteroendocrine cells include gastrin, somatostatin, ghrelin, and histamine. Gastrin stimulates gastric acid secretion and contributes to the regulation of gastric motility. Somatostatin inhibits the release of several hormones, including gastrin, and acts as a local regulator of gastrointestinal function. Ghrelin, often referred to as the hunger hormone, stimulates appetite and influences energy balance. Histamine, produced by enterochromaffin-like cells, plays a role in stimulating gastric acid secretion. The intricate coordination of these hormones helps regulate gastric acid production, nutrient absorption, and overall digestive function. Dysfunction in gastric enteroendocrine cells can lead to various gastrointestinal disorders, including peptic ulcers and gastritis. Understanding the roles and regulatory mechanisms of these cells is crucial for unraveling the complexities of gastrointestinal physiology and exploring potential therapeutic avenues for digestive disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy